Camber Pharmaceuticals Launches Generic Pepcid®

Piscataway, NJ, November 27, 2023–Camber Pharmaceuticals is pleased to announce the addition of Famotidine Powder for Oral Suspension, USP to its current portfolio.

Famotidine Powder for Oral Suspension, USP is indicated:

In adults for the treatment of:

  • active duodenal ulcer (DU).
  • active gastric ulcer (GU).
  • symptomatic nonerosive gastroesophageal reflux disease (GERD).
  • erosive esophagitis due to GERD, diagnosed by biopsy.
  • treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias).
  • reduction of the risk of DU recurrence.

In pediatric patients 1 year of age and older for the treatment of:

  • peptic ulcer disease.
  • GERD with or without esophagitis and ulcerations.

In pediatric patients from birth to less than 1 year of age for the treatment of:

  • GERD.

Famotidine 40 mg/5 mL Powder for Oral Suspension, USP is available in a bottle to make 50 mL when reconstituted as directed.

To find out more about Famotidine Powder for Oral Suspension, USP please visit

# # #

 If you would like more information about this topic, please contact Megan Little at [email protected]